Rankings
▼
Calendar
CMPX Q2 2024 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CMPX
Compass Therapeutics, Inc.
$781M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$850,000
Gross Profit
$850,000
100.0% margin
Operating Income
-$15M
-1770.0% margin
Net Income
-$13M
-1538.4% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$156M
Total Liabilities
$10M
Stockholders' Equity
$146M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$850,000
$0
—
Gross Profit
$850,000
$0
—
Operating Income
-$15M
-$13M
-12.8%
Net Income
-$13M
-$11M
-15.9%
← FY 2024
All Quarters
Q3 2024 →